Treatment of β-Thalassemia Patients with Recombinant Human Erythropoietin: Effect on Transfusion Requirements and Soluble Adhesion Molecules

Publisher： Karger

E-ISSN： 1421-9662|111|4|189-195

ISSN： 0001-5792

Source： Acta Haematologica, Vol.111, Iss.4, 2004-05, pp. : 189-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glomerular Hyperfiltration and Proteinuria in Transfusion-Independent Patients with β-Thalassemia Intermedia

By  

Nephron Clin Pract, Vol. 121, Iss. 3-4, 2012-12 ,pp. : c136-c143

Karger

Access to resources Recommend Favorite

Recombinant Human Erythropoietin for the Treatment of Anaemia in Patients with Chronic Idiopathic Myelofibrosis

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Lung Function in β-Thalassemia Patients: A Longitudinal Study

By  

Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. : 25-29

Karger

Access to resources Recommend Favorite

Premature Atherosclerosis in Non-Transfusion-Dependent β-Thalassemia Intermedia

By  

Cardiology, Vol. 118, Iss. 3, 2011-06 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study

By Scalone Luciana   Mantovani Lorenzo G.   Krol Marieke   Rofail Diana   Ravera Simona   Grazia Bisconte Maria   Borgna-Pignatti Caterina   Borsellino Zelia   Cianciulli Paolo   Gallisai Domenico   Prossomariti Luciano   Stefàno Ippazio   Cappellini Maria D.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1905-1917

Informa Healthcare

Access to resources Recommend Favorite